Last reviewed · How we verify

NCT06655727

Evaluation of Dysphagia in Patients Diagnosed With Parkinson's Disease by Ultrasound

Completed Last updated 29 January 2025
What this trial tests

trial testing Ultrasound evaluation in Parkinson Disease in 60 participants. Completed in 15 November 2024.

Timeline
25 October 2024
Primary endpoint
15 November 2024
15 November 2024

Quick facts

Lead sponsorBeylikduzu State Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date25 October 2024
Primary completion15 November 2024
Estimated completion15 November 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Beylikduzu State Hospital

Who can join

Adults 40 to 80, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this study is to perform an ultrasonographic swallowing assessment in Parkinson's patients and healthy volunteers and compare the findings with those from clinical swallowing evaluations. The secondary aim is to examine the relationship between dysphagia and functional status.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Ultrasound evaluation

Trials testing the same drug.

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Beylikduzu State Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06655727.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing